Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kohei Hamada

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Cancer Immunology, Immunotherapy : CII|February 7, 2026
Digital spatial profiling reveals additive effects of triple therapy on tumor microenvironment: anti-PD-L1, anti-VEGF, and PARP inhibition in mouse modelsAkihiko Ueda, Ryusuke Murakami, Kentaro Ishida, et al.
The Journal of Experimental Medicine|March 11, 2025
Correction: Myeloid activation clears ascites and reveals IL27-dependent regression of metastatic ovarian cancerBrennah Murphy, Taito Miyamoto, Bryan S Manning, et al.
The Journal of Experimental Medicine|November 21, 2024
Myeloid activation clears ascites and reveals IL27-dependent regression of metastatic ovarian cancerBrennah Murphy, Taito Miyamoto, Bryan S Manning, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
Intraperitoneal activation of myeloid cells clears ascites and reveals IL27-dependent regression of metastatic ovarian cancerBrennah Murphy, Taito Miyamoto, Bryan S Manning, et al.
Cancer Immunology, Immunotherapy : CII|February 16, 2026
Title: AI-based quantification of tumor-infiltrating lymphocytes with integrative transcriptomics in ovarian clear cell carcinoma: JGOG3025-TR1/A1 studyKohei Hamada, Junzo Hamanishi, Akihiko Ueda, et al.
Cancer Science|July 10, 2026
AI-Based Analysis of Tumor-Infiltrating Lymphocytes and Homologous Recombination in Ovarian Cancer: JGOG3025-A1 StudyKohei Hamada, Junzo Hamanishi, Noriomi Matsumura, et al.
Cancer Immunology, Immunotherapy : CII|February 1, 2025
Artificial intelligence-based spatial analysis of tertiary lymphoid structures and clinical significance for endometrial cancerHaruka Suzuki, Kohei Hamada, Junzo Hamanishi, et al.
Molecular Cancer Therapeutics|March 12, 2026
A novel CDK12 inhibitor induces homologous recombination deficiency to enhance PARP inhibitor efficacy in uterine serous carcinomaShunsuke Kawahara, Mana Taki, Junzo Hamanishi, et al.
Journal for Immunotherapy of Cancer|June 3, 2026
Chemotherapy induces an IL1β-dependent neutrophil recruitment and activation that promote chemoresistance in metastatic ovarian cancerTaito Miyamoto, Yujie Ye, Marlaine M Soliman, et al.
Clinical Rehabilitation|October 16, 2016
Independent exercise for glottal incompetence to improve vocal problems and prevent aspiration pneumonia in the elderly: a randomized controlled trialYoko Fujimaki, Koichi Tsunoda, Rika Kobayashi, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cancer Immunology, Immunotherapy : CII|February 7, 2026
Digital spatial profiling reveals additive effects of triple therapy on tumor microenvironment: anti-PD-L1, anti-VEGF, and PARP inhibition in mouse modelsAkihiko Ueda, Ryusuke Murakami, Kentaro Ishida, et al.
The Journal of Experimental Medicine|March 11, 2025
Correction: Myeloid activation clears ascites and reveals IL27-dependent regression of metastatic ovarian cancerBrennah Murphy, Taito Miyamoto, Bryan S Manning, et al.
The Journal of Experimental Medicine|November 21, 2024
Myeloid activation clears ascites and reveals IL27-dependent regression of metastatic ovarian cancerBrennah Murphy, Taito Miyamoto, Bryan S Manning, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
Intraperitoneal activation of myeloid cells clears ascites and reveals IL27-dependent regression of metastatic ovarian cancerBrennah Murphy, Taito Miyamoto, Bryan S Manning, et al.
Cancer Immunology, Immunotherapy : CII|February 16, 2026
Title: AI-based quantification of tumor-infiltrating lymphocytes with integrative transcriptomics in ovarian clear cell carcinoma: JGOG3025-TR1/A1 studyKohei Hamada, Junzo Hamanishi, Akihiko Ueda, et al.
Cancer Science|July 10, 2026
AI-Based Analysis of Tumor-Infiltrating Lymphocytes and Homologous Recombination in Ovarian Cancer: JGOG3025-A1 StudyKohei Hamada, Junzo Hamanishi, Noriomi Matsumura, et al.
Cancer Immunology, Immunotherapy : CII|February 1, 2025
Artificial intelligence-based spatial analysis of tertiary lymphoid structures and clinical significance for endometrial cancerHaruka Suzuki, Kohei Hamada, Junzo Hamanishi, et al.
Molecular Cancer Therapeutics|March 12, 2026
A novel CDK12 inhibitor induces homologous recombination deficiency to enhance PARP inhibitor efficacy in uterine serous carcinomaShunsuke Kawahara, Mana Taki, Junzo Hamanishi, et al.
Journal for Immunotherapy of Cancer|June 3, 2026
Chemotherapy induces an IL1β-dependent neutrophil recruitment and activation that promote chemoresistance in metastatic ovarian cancerTaito Miyamoto, Yujie Ye, Marlaine M Soliman, et al.
Clinical Rehabilitation|October 16, 2016
Independent exercise for glottal incompetence to improve vocal problems and prevent aspiration pneumonia in the elderly: a randomized controlled trialYoko Fujimaki, Koichi Tsunoda, Rika Kobayashi, et al.
Pageof 3